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Abstract. This project introduces a simulation of Proportional-Derivative (PD) and Proportional-Integral-Derivative 
(PID) controller based on a virtual Type 1 Diabetes Mellitus (T1DM) patient: Hovorka diabetic model using MATLAB-
Simulink software. The results of these simulations are based on three tuning responses for each controller which are fast, 
slow and oscillation responses. The main purpose of this simulation is to achieve an acceptable stability and fastness 
response towards the regulation of glucose concentration using PD and PID controller response with insulin infusion rate. 
Therefore, in order to analyze and compare the responses of both controller performances, one-day simulations of the 
insulin-glucose dynamic have been conducted using a typical day meal plan that contains five meals of different bolus 
size. It is found that the PID closed-loop control with a short rise time is required to retrieve a satisfactory glucose 
regulation. 
INTRODUCTION 
Diabetes mellitus is a common group of diseases characterized by high blood-glucose levels that results the lack 
of insulin production or insulin action in the body. According to International Diabetes Federation (IDF), in 2014, 
there were 385 millions of people worldwide suffering from DM which most of the numbers come from Western 
Pacific regions such as Malaysia, China and Cambodia. This figure is expected to increase to 592 million on 2035 
[1]. These statistics and predictions is driven to an efficient research to conduct in order to increase the prevention, 
improve methods and ideally to find a treatment for Type 1 Diabetes Mellitus (T1DM) patient. This study focuses 
on T1DM to regulate the blood glucose level through exogenous insulin control. People with T1DM are insulin 
dependents and they are not able to produce sufficient amounts of insulin themselves, opposite to the people without 
diabetes who can produce insulin in the pancreas.  
Insulin is a hormone that is critical to the regulation of glucose concentration in the blood, and without it the 
blood glucose level is often too high (hyperglycemia), which can cause long-term problems like eye, nerve, kidney 
diseases, and strokes, on the other hand overdose of the insulin will cause low blood glucose (hypoglycemia) that 
can result in the patient to fall into coma or have other immediate consequences. Therefore insulin must be injected 
to regulate the blood glucose concentration in order to decrease the glucose level in the blood so that the glucose 
concentration can be kept near to the normaglycemic level (3.89 – 7.78 mmol/L) [2]. Furthermore it is very crucial 
to inject a suitable amount to the patient, because if too much insulin is injected, the blood glucose concentration 
level decreases too much and causes the patient into hypoglycemia [3]. However, direct testing on human subjects 
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for development and evaluation of an adaptive system to deliver insulin treatment for T1DM is time-consuming, 
costly, and confounded by ethical issues. Therefore, recently, continuous research on diabetes control is being 
managed via in-silico experiment through mathematical modeling of the insulin-glucose system [4-6].   
In this study a non-linear compartmental model referred as Hovorka model [7-9] with a control algorithm is used 
to simulate how much insulin pump should infuse when meals are consumed. This is because the blood glucose 
concentration is also affected when the patient intakes a meal, because the carbohydrates from the meal are absorbed 
by the body and are converted into glucose in the blood so, this causes the blood glucose concentration level to 
become too high [10].Through this model, information about the behavior of the T1DM patient can be gained to 
help find a suitable way of administrating insulin injections. In other word, the Hovorka model is used to represent 
as virtual T1DM patient in the analysis system of insulin control in regulating the blood glucose level since it is 
often used and reliable model to represent the Type 1 Diabetes [11]. This control mechanism is done by using 
Proportional-integral-derivative (PID) control which is widely used in control systems. The function of the PID 
controller is closely parallel to the β-cells biphasic insulin response that can detect and slowly increase insulin 
secretion until the blood glucose level has decreased to normal condition [12]. 
METHODOLOGY 
Figure 1 shows the block diagram of the closed-loop PD/PID control system for insulin control on blood glucose 
regulation in Type 1 Diabetes Mellitus (T1DM) represented using Hovorka diabetic model as the virtual patient. 
According to the block diagram, the insulin input to the virtual patient is depending upon the difference between the 
actual blood glucose concentration from the feedback loop and desired blood glucose concentration from the glucose 
reference input, which is called as error of the system. Then, this error signal is fed to the PD/PID control system to 
estimate the amount of insulin input into the virtual T1DM patient represented using the Hovorka diabetic model in 
regulating the blood glucose concentration. Moreover, the meal disturbance for certain durations is also input several 
times to the Hovorka diabetic model to represent as the blood glucose effecting factor. 
Hovorka diabetic model that is used in this system to stand for the T1DM patient is a nonlinear Ordinary 
Differential Equation (ODE) model of glucose and insulin kinetics. The model describes the relationship between 
subcutaneous insulin in-fusion and intravenous glucose concentration given a specified meal disturbance for T1DM 
patient. The model is described by ten ODEs and consists of three subsystems which are carbohydrate (CHO) 
absorption, subcutaneous insulin absorption and gluco-regulatory subsystems [9].  
The PD/PID controller represents as an insulin pump which continuously conducts the injection into the patient’s 
body. It is set to deliver flow rates between 6.68 and 800 mU/min of insulin infusion rate. The controller The PID 
controller calculates the insulin delivery based on function of the three terms: 
• Proportional term (P): it adjusts the insulin delivery in response to the current glucose measured level. 
• Integral term (I): adjusts insulin delivery according to the area under the curve between measured and 
target glucose set point (SP). 
• Derivative term (D): delivers insulin in response to the rate of change of blood glucose over time. 
 
 
 
FIGURE 1. General block diagram of the PD/PID control system for insulin control on blood glucose regulation 
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This system design is done by using MATLAB-Simulink software to simulate the PD/PID controller with the 
Hovorka model. The controller has been used to control the insulin infusion rate to maintain the glucose 
concentration in a basal level. The simulation start at 0.0 and stop at 1440 sample time, which represent 24 hours or 
one day simulation. Figure 2 below shows the designed MATLAB-Simulink block diagrams of the PD/PID control 
system for insulin control on blood glucose regulation in Hovorka diabetic model. Generally this MATLAB 
Simulink based PD/PID Control System consists of several parts which are the S-function block to represent the 
ODE based mathematical descriptions from the Hovorka model which are then solved using MATLAB ODE solver 
function of ode45, the controller block that is used to control insulin amount to be injected based on the error signal 
from the blood glucose feedback, the glucose set point as the reference value for the glucose control mechanism, the 
pulse generator block to represent inputs for the meal disturbance and lastly, the blood glucose display and data 
storage to analyze the outcome of the system. 
 
 
 
FIGURE 2. MATLAB-Simulink block diagrams of the PD/PID control system for insulin control on blood glucose regulation in 
Hovorka diabetic model 
RESULTS AND DISCUSSION 
The simulation results of the insulin control on blood glucose regulation in Hovorka diabetic model using the 
PD/PID controller are based on three tuning responses from each controller which are fast, slow and oscillating 
response. The performance of both controllers has been compared in order to determine which controller has the 
optimum tuning response to maintain the blood glucose level of the Type-1 Diabetes Mellitus (T1DM) patient in 
normaglycemic range.   
PD and PID Tunings with Fast Response  
The values shown in Table 1 is the summary of the tuned results of PD and PID controller of fast response 
tuning and, Fig. 3 (a) and (b), respectively show the transfer function of PD and PID controllers tuned in fast 
response.  
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TABLE 1. PD/PID parameters in fast response tuning 
 
 
 
 
 
   
                                     (a)                                                                                       (b) 
 
FIGURE 3. Fast response transfer function for (a) PD and (b) PID controllers 
 
While, Fig. 4 (a) and (b) show the simulation results of glucose concentration using the PD and PID controller, 
respectively based on fast tuning response. According to these results it shows that fast response or fast rise time in 
the transfer function has led to a better blood glucose concentration regulation in both PD and PID controllers. 
Based on the parameters in the Table 1, the tuned parameters in PD controller causes steady state error, which makes 
it hard to reduce the hyperglycemia in the glucose concentration and makes it hard for the glucose concentration to 
reach its set point, however the I parameter of PID controller eliminates the steady state error therefore gives lower 
glucose concentration compare to the PD controller. Besides, N is stand for filter coefficient which works with the 
Derivative D parameter to decrease the noise sensitivity by setting the approximate frequency in the controller. 
   
                                   (a)                                                                                 (b) 
 
FIGURE 4. Simulation results of the blood glucose concentration in fast response for (a) PD and (b) PID controllers 
 
PD tuner 
parameters 
PID tuner 
parameters 
Values 
PD PID 
P -1.24936 -2 
I - 0.0010 
D 164.58467 140 
N 0.9116 1.77 
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PD and PID Tunings with Slow Response  
The results of tuned parameters for the PD and PID in slow response are listed in Table 2 and Fig. 5 (a) and (b) 
show the transfer function of PD and PID controller, respectively tuned in slow response. 
 
TABLE 2. PD/PID parameters in slow response tuning 
 
 
 
 
 
 
 
 
   
                                       (a)                                                                                         (b) 
 
FIGURE 5. Slow response transfer function for (a) PD and (b) PID controllers 
 
Figure 6 (a) and (b) show the simulation results of glucose concentration using the PD and PID controller, 
respectively based on slow tuning response. According to these results it shows that slow response or slow rise time 
in the transfer function has led to an increase in the blood glucose concentration in both PD and PID controllers. By 
referring to the setting parameters of PD and PID controllers in Table 2, the proportional P parameters of both 
controllers have a small value that cannot overcome any hyperglycemia in the glucose concentration due to the rise 
time happened when tuning with slow response. Furthermore PD controller has a large steady state error which 
makes it hard for the glucose concentration to reach its set point. The derivative D parameter values for both 
controllers can eliminate any settling time to occur in the glucose concentration however because of its value is zero 
it gives no effect to the blood glucose regulation. While, integral, I parameter for PID controller tuning uses a small 
value which causes a slow rise time to happen, therefore, this value cannot overcome the hypoglycemia state. 
 
   
                                     (a)                                                                             (b) 
 
FIGURE 6. Simulation results of the blood glucose concentration in slow response for (a) PD and (b) PID controllers 
 
 
PD tuner 
parameters 
PID tuner 
parameters 
Values 
PD PID 
P -0.484 -0.2752 
I - 0.00149 
D 0 0 
N 100 100 
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PD and PID Tunings with Oscillation Response 
 
Figure 7 (a) and (b) show the transfer function of PD and PID controller, respectively tuned in oscillation 
response based on the tuned parameters for the PD and PID listed in Table 3.
 
  
                                        (a)                                                                                        (b) 
 
FIGURE 7. Oscillation response transfer function for (a) PD and (b) PID controllers 
 
TABLE 3. PD/PID parameters in oscillation response tuning 
 
 
 
 
 
Figure 8 (a) and (b), respectively shows the simulation results of glucose concentration using PD and PID 
controller tuning adjusted to the oscillating response. According to these results it shows that the oscillating response 
in the transfer function has led to instability of the blood glucose concentration regulation in both PD and PID 
controller. Based on the tuned parameters in the Table 3, the proportional, P parameter for both controllers has a 
large value that can make faster response but can cause overshoot and give poor stability to the glucose 
concentration. The derivative, D parameter for both controllers also have a large value that leads to overcome and 
decrease overshoot to happen but due to noise enlargements the derivative, D parameter become larger and due to 
the proportional, P parameter may has dominated the effect over the derivative, D parameter, these lead to instability 
of the blood glucose regulation. Besides, the integral, I parameter value for PID controller may has given a large 
settling time and overshoot which can cause the glucose concentration to overdose and lead to hypoglycemia 
because of high insulin input. 
 
  
                                  (a)                                                                               (b) 
 
FIGURE 8. Simulation results of the blood glucose concentration in oscillation response for (a) PD and (b) PID controllers 
 
PD tuner 
parameters 
PID tuner 
parameters 
Values 
PD PID 
P -7.5927 -5.956 
I - 0.00176 
D 91.65 128.1326 
N 3.116105 3.23440 
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CONCLUSIONS 
Based on all the results discussed, it is found that in order to retrieve a satisfactory glucose regulation through the 
Proportional-Derivative (PD) /Proportional-Integral-Derivative (PID) control, the parameter settings towards closed-
loop responses of a short rise time, steady-state error elimination and, overshoot and setting time decrement are 
required. By comparing with the PD controller, the PID controller has provided a better control for those closed-loop 
responses. Therefore, the PID controller with a fast response gives an optimum control of the glucose regulation 
compared to the PD controller, because of the integral action can eliminate the steady-state error and furthermore 
can decrease the rise time of the controller transfer function while at the same time the derivative parameter an 
remove any overshoot and shorten the settling time of the controller transfer function. 
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